{"id":"https://openalex.org/W3092023973","doi":"https://doi.org/10.1158/1557-3125.pi3k-mtor18-pr04","title":"Abstract PR04: 4EBP1 reactivation by potent and selective bi-steric inhibitors of mTORC1","display_name":"Abstract PR04: 4EBP1 reactivation by potent and selective bi-steric inhibitors of mTORC1","publication_year":2020,"publication_date":"2020-10-01","ids":{"openalex":"https://openalex.org/W3092023973","doi":"https://doi.org/10.1158/1557-3125.pi3k-mtor18-pr04","mag":"3092023973"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3125.pi3k-mtor18-pr04","doi":"https://doi.org/10.1158/1557-3125.pi3k-mtor18-pr04","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3125.pi3k-mtor18-pr04","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014282065","display_name":"Nidhi Tibrewal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nidhi Tibrewal","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062983432","display_name":"James B. Aggen","orcid":"https://orcid.org/0000-0001-7989-5131","observed_orcids":["https://orcid.org/0000-0001-7989-5131"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James B. Aggen","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022861214","display_name":"Abraham I. Bassan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abraham I. Bassan","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031943362","display_name":"G. Leslie Burnett","orcid":"https://orcid.org/0000-0003-2514-9373","observed_orcids":["https://orcid.org/0000-0003-2514-9373"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Leslie Burnett","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102068936","display_name":"Jim Evans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jim Evans","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039513759","display_name":"Micah J. Gliedt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Micah J. Gliedt","raw_affiliation_strings":["2University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015468556","display_name":"Daphne Hsieh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daphne Hsieh","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019581942","display_name":"Gert Kiss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gert Kiss","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090760997","display_name":"Bianca J. Lee","orcid":"https://orcid.org/0009-0000-4888-8684","observed_orcids":["https://orcid.org/0009-0000-4888-8684"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bianca J. Lee","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100370205","display_name":"Dong Hun Lee","orcid":"https://orcid.org/0000-0002-2925-3074","observed_orcids":["https://orcid.org/0000-0002-2925-3074","https://orcid.org/0009-0000-9114-4234"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dong Lee","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086613983","display_name":"Ed Lorenzana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ed Lorenzana","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012645194","display_name":"Abby Marquez","orcid":"https://orcid.org/0000-0001-5104-2823","observed_orcids":["https://orcid.org/0000-0001-5104-2823"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abby Marquez","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054158277","display_name":"Arun P. Thottumkara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arun Thottumkara","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102845474","display_name":"Zhengping Wang","orcid":"https://orcid.org/0000-0001-5928-3816","observed_orcids":["https://orcid.org/0000-0001-5928-3816"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhengping Wang","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006843660","display_name":"Stacy L. Wilson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stacy Wilson","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013456495","display_name":"Frances Zhao","orcid":"https://orcid.org/0000-0001-5924-987X","observed_orcids":["https://orcid.org/0000-0001-5924-987X"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frances Zhao","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021689661","display_name":"Mark A. Goldsmith","orcid":"https://orcid.org/0000-0001-8833-6841","observed_orcids":["https://orcid.org/0000-0001-8833-6841"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Goldsmith","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057362852","display_name":"Mallika Singh","orcid":"https://orcid.org/0009-0003-0234-1589","observed_orcids":["https://orcid.org/0009-0003-0234-1589"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mallika Singh","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049716299","display_name":"Pete Wildes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pete Wildes","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022776516","display_name":"Adrian L. Gill","orcid":"https://orcid.org/0009-0003-0914-4860","observed_orcids":["https://orcid.org/0009-0003-0914-4860"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adrian L. Gill","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027330002","display_name":"Jacqueline A.M. Smith","orcid":"https://orcid.org/0000-0001-5028-8725","observed_orcids":["https://orcid.org/0000-0001-5028-8725"]},"institutions":[{"id":"https://openalex.org/I4210100604","display_name":"Revolution Medicines (United States)","ror":"https://ror.org/00mny1y94","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100604"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacqueline A.M. Smith","raw_affiliation_strings":["1Revolution Medicines, Redwood City, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Revolution Medicines, Redwood City, CA,","institution_ids":["https://openalex.org/I4210100604"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"10_Supplement","first_page":"PR04","last_page":"PR04"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mtorc1-inhibition","display_name":"mTORC1 inhibition","score":0.8009999990463257},{"id":"https://openalex.org/keywords/4e-bp1-phosphorylation","display_name":"4E-BP1 phosphorylation","score":0.9300000071525574},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.9129999876022339},{"id":"https://openalex.org/keywords/rapamycin-analogues","display_name":"rapamycin analogs","score":0.7760000228881836},{"id":"https://openalex.org/keywords/atp-competitive-inhibitors","display_name":"ATP-competitive inhibitors","score":0.7739999890327454},{"id":"https://openalex.org/keywords/cap-dependent-translation","display_name":"cap-dependent translation","score":0.578000009059906},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.527999997138977},{"id":"https://openalex.org/keywords/mcf-7-xenografts","display_name":"MCF-7 xenografts","score":0.6990000009536743}],"concepts":[{"id":"https://openalex.org/C107846503","wikidata":"https://www.wikidata.org/wiki/Q14876061","display_name":"mTORC2","level":5,"score":0.9214920401573181},{"id":"https://openalex.org/C98490376","wikidata":"https://www.wikidata.org/wiki/Q14876060","display_name":"mTORC1","level":4,"score":0.9087275862693787},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.8025330305099487},{"id":"https://openalex.org/C104202773","wikidata":"https://www.wikidata.org/wiki/Q18031289","display_name":"P70-S6 Kinase 1","level":4,"score":0.6131863594055176},{"id":"https://openalex.org/C2777949483","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"Mechanistic target of rapamycin","level":4,"score":0.5295423269271851},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5144155621528625},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.4899684488773346},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4656347334384918},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4541837275028229},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4441995620727539},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.44329750537872314},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3741750419139862},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.29704880714416504}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3125.pi3k-mtor18-pr04","doi":"https://doi.org/10.1158/1557-3125.pi3k-mtor18-pr04","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3125.pi3k-mtor18-pr04","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3095068463","https://openalex.org/W4362594704","https://openalex.org/W3179566271","https://openalex.org/W4388041421","https://openalex.org/W3177289604","https://openalex.org/W2406952418","https://openalex.org/W107662779","https://openalex.org/W38458730","https://openalex.org/W2150981403","https://openalex.org/W7097461712"],"abstract_inverted_index":{"Abstract":[0],"Aberrant":[1],"activation":[2],"of":[3,17,77,90,94,120,133,143,160,163,173,188,215,228,253,262,284,295,311,331,378,394,397,410,483,488],"the":[4,53,75,139,144,150,156,183,200,260,263,391,489],"PI3K/AKT/mTOR":[5],"pathway":[6,26],"is":[7,20,417],"implicated":[8],"in":[9,24,29,127,155,232,255,299,301,314,348,364,367],"human":[10],"cancer.":[11],"The":[12,116,208],"protein":[13,38,58],"kinase":[14,47],"mechanistic":[15],"target":[16],"rapamycin":[18],"(mTOR)":[19],"a":[21,170,178,334,361,368],"key":[22],"node":[23],"this":[25],"and":[27,33,50,81,112,158,185,205,230,250,265,306,322,344,389,479],"participates":[28],"two":[30],"complexes:":[31],"mTORC1":[32,35,165,217,229,254,375,484],"mTORC2.":[34],"regulates":[36,62],"cap-dependent":[37],"translation,":[39],"both":[40,182,203],"by":[41,51,383,477],"activating":[42],"downstream":[43],"effectors,":[44],"including":[45,97,219],"p70S6":[46],"1":[48,59],"(S6K1),":[49],"deactivating":[52],"translation-initiation":[54],"repressor":[55],"eIF4E":[56],"binding":[57],"(4EBP1).":[60],"mTORC2":[61,231,384],"cellular":[63],"proliferation":[64],"via":[65],"AKT":[66],"phosphorylation.":[67],"mTOR":[68,174,189,245,352,413],"inhibitors":[69,147,246,272,291,359,482],"have":[70,195,241,269],"diverse":[71,411],"pharmacologic":[72],"effects":[73],"on":[74,493],"activity":[76,119,135],"these":[78],"complexes.":[79],"Rapamycin":[80],"its":[82],"analogs":[83],"(rapalogs)":[84],"cause":[85],"selective":[86,251,480],"but":[87,99,221],"incomplete":[88],"inhibition":[89,162,227,252,294],"mTORC1,":[91,110],"reducing":[92],"phosphorylation":[93,214,298,343],"some":[95],"substrates,":[96,218],"S6K1,":[98],"not":[100,339],"4EBP1.":[101],"In":[102,326],"contrast,":[103,327],"ATP-competitive":[104,266],"inhibitors,":[105,376],"such":[106],"as":[107,279,281,421],"MLN0128,":[108],"inhibit":[109],"mTORC2,":[111],"various":[113],"lipid":[114],"kinases.":[115],"suboptimal":[117],"antitumor":[118],"rapalogs":[121],"has":[122,190],"been":[123,191],"attributed,":[124],"at":[125,166,317,333],"least":[126],"part,":[128],"to":[129,198,373],"their":[130],"limited":[131],"spectrum":[132],"inhibitory":[134,141],"against":[136],"mTORC1.":[137],"Conversely,":[138],"broad":[140],"profile":[142],"ATP":[145],"competitive":[146],"may":[148],"be":[149,402],"basis":[151],"for":[152],"observed":[153],"toxicities":[154],"clinic":[157],"lack":[159],"optimal":[161],"tumor":[164,296,324,341],"tolerated":[167],"doses.":[168],"Recently,":[169],"new":[171],"class":[172],"inhibitor":[175],"that":[176,247,273,319,400],"exploits":[177],"bivalent":[179],"interaction":[180,201],"with":[181,202,350,357,404],"ATP-":[184],"FRB-binding":[186],"sites":[187],"reported,":[192],"which":[193],"we":[194,240,268],"termed":[196],"\u201cbi-steric\u201d":[197],"reflect":[199],"allosteric":[204],"orthosteric":[206],"sites.":[207],"prototype":[209],"bi-steric":[210,244,271,290,351,412,481],"inhibitor,":[211],"RapaLink-1,":[212],"blocks":[213],"many":[216],"4EBP1,":[220],"exhibits":[222],"only":[223],"modest":[224],"differentiation":[225],"between":[226],"vitro.":[233,256],"Using":[234],"our":[235,408],"Revblocks\u00ae":[236],"\u201cmodular":[237],"synthesis\u201d":[238],"platform,":[239],"generated":[242],"novel":[243],"exhibit":[248,274],"potent":[249,478],"By":[257],"independently":[258],"tuning":[259],"affinities":[261],"rapamycin-derived":[264],"moieties,":[267],"designed":[270],"distinct":[275],"mTORC1/2":[276,398],"selectivity":[277,399],"profiles":[278,393],"well":[280],"different":[282,395],"durations":[283],"action.":[285],"Following":[286],"intraperitoneal":[287],"administration,":[288],"mTORC1-selective":[289,358],"produced":[292],"sustained":[293,323],"4EBP1":[297,342,475],"vivo":[300],"MCF7,":[302],"an":[303],"estrogen":[304],"receptor-positive":[305],"PI3KCA":[307],"mutant":[308],"xenograft":[309],"model":[310],"mammary":[312],"carcinoma":[313],"nude":[315],"mice,":[316],"doses":[318],"induced":[320],"rapid":[321],"regression.":[325],"daily":[328],"oral":[329],"administration":[330],"everolimus":[332],"clinically":[335],"relevant":[336],"dose":[337],"did":[338],"alter":[340],"was":[345],"less":[346],"efficacious":[347],"comparison":[349],"inhibitors.":[353,414],"Na\u00efve":[354],"mice":[355],"treated":[356],"showed":[360],"reduced":[362,379],"spike":[363],"blood":[365],"glucose":[366,369],"tolerance":[370],"test":[371],"compared":[372],"nonselective":[374],"indicative":[377],"insulin":[380],"resistance":[381],"driven":[382],"inhibition.":[385],"We":[386],"will":[387],"compare":[388],"contrast":[390],"biologic":[392],"levels":[396],"can":[401],"achieved":[403],"selected":[405],"examples":[406],"from":[407],"collection":[409],"This":[415],"abstract":[416],"also":[418],"being":[419],"presented":[420],"Poster":[422],"A19.":[423],"Citation":[424],"Format:":[425],"Nidhi":[426],"Tibrewal,":[427],"James":[428],"B.":[429],"Aggen,":[430],"Abraham":[431],"I.":[432],"Bassan,":[433],"G.":[434],"Leslie":[435],"Burnett,":[436],"Jim":[437],"Evans,":[438],"Micah":[439],"J.":[440,447],"Gliedt,":[441],"Daphne":[442],"Hsieh,":[443],"Gert":[444],"Kiss,":[445],"Bianca":[446],"Lee,":[448,450],"Dong":[449],"Ed":[451],"Lorenzana,":[452],"Abby":[453],"Marquez,":[454],"Arun":[455],"Thottumkara,":[456],"Zhengping":[457],"Wang,":[458],"Stacy":[459],"Wilson,":[460],"Frances":[461],"Zhao,":[462],"Mark":[463],"Goldsmith,":[464],"Mallika":[465],"Singh,":[466],"Pete":[467],"Wildes,":[468],"Adrian":[469],"L.":[470],"Gill,":[471],"Jacqueline":[472],"A.M.":[473],"Smith.":[474],"reactivation":[476],"[abstract].":[485],"In:":[486],"Proceedings":[487],"AACR":[490],"Special":[491],"Conference":[492],"Targeting":[494],"PI3K/mTOR":[495],"Signaling;":[496],"2018":[497],"Nov":[498],"30-Dec":[499],"8;":[500],"Boston,":[501],"MA.":[502],"Philadelphia":[503],"(PA):":[504],"AACR;":[505],"Mol":[506],"Cancer":[507],"Res":[508],"2020;18(10_Suppl):Abstract":[509],"nr":[510],"PR04.":[511]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2020-10-15T00:00:00"}